Retrovirus is a single stranded RNA virus that is composed of an enzyme called reverse transcriptase. With the help of reverse transcriptase, retroviral RNA gets transcribed into retroviral DNA once it enters into a host cell.
Highlights
The global Retrovirus Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Retrovirus Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Retrovirus Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Retrovirus Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Retrovirus Testing include Abbott Diagnostics, Roche, DiaSorin, ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ, BD, Sansure Biotech, BGI Genomics, Wondfo Biotech and Hybribio Biotech, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Retrovirus Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retrovirus Testing.
The Retrovirus Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Retrovirus Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Retrovirus Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott Diagnostics
Roche
DiaSorin
²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ
BD
Sansure Biotech
BGI Genomics
Wondfo Biotech
Hybribio Biotech
Lepu Medical
Amoy Diagnostics
Xilong Scientific
ZJ Bio-Tech Co., Ltd.
Tellgen Corporation
Bioperfectus Technologies
Kehua Bio-Engineering
EasyDiagnosis
Dian Diagnostics
Segment by Type
Blood
Serum
Body Fluids
Cells
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Retrovirus Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retrovirus Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Blood
1.2.3 Serum
1.2.4 Body Fluids
1.2.5 Cells
1.3 Market by Application
1.3.1 Global Retrovirus Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Retrovirus Testing Market Perspective (2018-2029)
2.2 Retrovirus Testing Growth Trends by Region
2.2.1 Global Retrovirus Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Retrovirus Testing Historic Market Size by Region (2018-2023)
2.2.3 Retrovirus Testing Forecasted Market Size by Region (2024-2029)
2.3 Retrovirus Testing Market Dynamics
2.3.1 Retrovirus Testing Industry Trends
2.3.2 Retrovirus Testing Market Drivers
2.3.3 Retrovirus Testing Market Challenges
2.3.4 Retrovirus Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retrovirus Testing Players by Revenue
3.1.1 Global Top Retrovirus Testing Players by Revenue (2018-2023)
3.1.2 Global Retrovirus Testing Revenue Market Share by Players (2018-2023)
3.2 Global Retrovirus Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Retrovirus Testing Revenue
3.4 Global Retrovirus Testing Market Concentration Ratio
3.4.1 Global Retrovirus Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retrovirus Testing Revenue in 2022
3.5 Retrovirus Testing Key Players Head office and Area Served
3.6 Key Players Retrovirus Testing Product Solution and Service
3.7 Date of Enter into Retrovirus Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Retrovirus Testing Breakdown Data by Type
4.1 Global Retrovirus Testing Historic Market Size by Type (2018-2023)
4.2 Global Retrovirus Testing Forecasted Market Size by Type (2024-2029)
5 Retrovirus Testing Breakdown Data by Application
5.1 Global Retrovirus Testing Historic Market Size by Application (2018-2023)
5.2 Global Retrovirus Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Retrovirus Testing Market Size (2018-2029)
6.2 North America Retrovirus Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Retrovirus Testing Market Size by Country (2018-2023)
6.4 North America Retrovirus Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Retrovirus Testing Market Size (2018-2029)
7.2 Europe Retrovirus Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Retrovirus Testing Market Size by Country (2018-2023)
7.4 Europe Retrovirus Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Retrovirus Testing Market Size (2018-2029)
8.2 Asia-Pacific Retrovirus Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Retrovirus Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Retrovirus Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Retrovirus Testing Market Size (2018-2029)
9.2 Latin America Retrovirus Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Retrovirus Testing Market Size by Country (2018-2023)
9.4 Latin America Retrovirus Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retrovirus Testing Market Size (2018-2029)
10.2 Middle East & Africa Retrovirus Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Retrovirus Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Retrovirus Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Detail
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Retrovirus Testing Introduction
11.1.4 Abbott Diagnostics Revenue in Retrovirus Testing Business (2018-2023)
11.1.5 Abbott Diagnostics Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Retrovirus Testing Introduction
11.2.4 Roche Revenue in Retrovirus Testing Business (2018-2023)
11.2.5 Roche Recent Development
11.3 DiaSorin
11.3.1 DiaSorin Company Detail
11.3.2 DiaSorin Business Overview
11.3.3 DiaSorin Retrovirus Testing Introduction
11.3.4 DiaSorin Revenue in Retrovirus Testing Business (2018-2023)
11.3.5 DiaSorin Recent Development
11.4 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ
11.4.1 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Company Detail
11.4.2 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Business Overview
11.4.3 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Retrovirus Testing Introduction
11.4.4 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Revenue in Retrovirus Testing Business (2018-2023)
11.4.5 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD Retrovirus Testing Introduction
11.5.4 BD Revenue in Retrovirus Testing Business (2018-2023)
11.5.5 BD Recent Development
11.6 Sansure Biotech
11.6.1 Sansure Biotech Company Detail
11.6.2 Sansure Biotech Business Overview
11.6.3 Sansure Biotech Retrovirus Testing Introduction
11.6.4 Sansure Biotech Revenue in Retrovirus Testing Business (2018-2023)
11.6.5 Sansure Biotech Recent Development
11.7 BGI Genomics
11.7.1 BGI Genomics Company Detail
11.7.2 BGI Genomics Business Overview
11.7.3 BGI Genomics Retrovirus Testing Introduction
11.7.4 BGI Genomics Revenue in Retrovirus Testing Business (2018-2023)
11.7.5 BGI Genomics Recent Development
11.8 Wondfo Biotech
11.8.1 Wondfo Biotech Company Detail
11.8.2 Wondfo Biotech Business Overview
11.8.3 Wondfo Biotech Retrovirus Testing Introduction
11.8.4 Wondfo Biotech Revenue in Retrovirus Testing Business (2018-2023)
11.8.5 Wondfo Biotech Recent Development
11.9 Hybribio Biotech
11.9.1 Hybribio Biotech Company Detail
11.9.2 Hybribio Biotech Business Overview
11.9.3 Hybribio Biotech Retrovirus Testing Introduction
11.9.4 Hybribio Biotech Revenue in Retrovirus Testing Business (2018-2023)
11.9.5 Hybribio Biotech Recent Development
11.10 Lepu Medical
11.10.1 Lepu Medical Company Detail
11.10.2 Lepu Medical Business Overview
11.10.3 Lepu Medical Retrovirus Testing Introduction
11.10.4 Lepu Medical Revenue in Retrovirus Testing Business (2018-2023)
11.10.5 Lepu Medical Recent Development
11.11 Amoy Diagnostics
11.11.1 Amoy Diagnostics Company Detail
11.11.2 Amoy Diagnostics Business Overview
11.11.3 Amoy Diagnostics Retrovirus Testing Introduction
11.11.4 Amoy Diagnostics Revenue in Retrovirus Testing Business (2018-2023)
11.11.5 Amoy Diagnostics Recent Development
11.12 Xilong Scientific
11.12.1 Xilong Scientific Company Detail
11.12.2 Xilong Scientific Business Overview
11.12.3 Xilong Scientific Retrovirus Testing Introduction
11.12.4 Xilong Scientific Revenue in Retrovirus Testing Business (2018-2023)
11.12.5 Xilong Scientific Recent Development
11.13 ZJ Bio-Tech Co., Ltd.
11.13.1 ZJ Bio-Tech Co., Ltd. Company Detail
11.13.2 ZJ Bio-Tech Co., Ltd. Business Overview
11.13.3 ZJ Bio-Tech Co., Ltd. Retrovirus Testing Introduction
11.13.4 ZJ Bio-Tech Co., Ltd. Revenue in Retrovirus Testing Business (2018-2023)
11.13.5 ZJ Bio-Tech Co., Ltd. Recent Development
11.14 Tellgen Corporation
11.14.1 Tellgen Corporation Company Detail
11.14.2 Tellgen Corporation Business Overview
11.14.3 Tellgen Corporation Retrovirus Testing Introduction
11.14.4 Tellgen Corporation Revenue in Retrovirus Testing Business (2018-2023)
11.14.5 Tellgen Corporation Recent Development
11.15 Bioperfectus Technologies
11.15.1 Bioperfectus Technologies Company Detail
11.15.2 Bioperfectus Technologies Business Overview
11.15.3 Bioperfectus Technologies Retrovirus Testing Introduction
11.15.4 Bioperfectus Technologies Revenue in Retrovirus Testing Business (2018-2023)
11.15.5 Bioperfectus Technologies Recent Development
11.16 Kehua Bio-Engineering
11.16.1 Kehua Bio-Engineering Company Detail
11.16.2 Kehua Bio-Engineering Business Overview
11.16.3 Kehua Bio-Engineering Retrovirus Testing Introduction
11.16.4 Kehua Bio-Engineering Revenue in Retrovirus Testing Business (2018-2023)
11.16.5 Kehua Bio-Engineering Recent Development
11.17 EasyDiagnosis
11.17.1 EasyDiagnosis Company Detail
11.17.2 EasyDiagnosis Business Overview
11.17.3 EasyDiagnosis Retrovirus Testing Introduction
11.17.4 EasyDiagnosis Revenue in Retrovirus Testing Business (2018-2023)
11.17.5 EasyDiagnosis Recent Development
11.18 Dian Diagnostics
11.18.1 Dian Diagnostics Company Detail
11.18.2 Dian Diagnostics Business Overview
11.18.3 Dian Diagnostics Retrovirus Testing Introduction
11.18.4 Dian Diagnostics Revenue in Retrovirus Testing Business (2018-2023)
11.18.5 Dian Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott Diagnostics
Roche
DiaSorin
²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ
BD
Sansure Biotech
BGI Genomics
Wondfo Biotech
Hybribio Biotech
Lepu Medical
Amoy Diagnostics
Xilong Scientific
ZJ Bio-Tech Co., Ltd.
Tellgen Corporation
Bioperfectus Technologies
Kehua Bio-Engineering
EasyDiagnosis
Dian Diagnostics
Ìý
Ìý
*If Applicable.